SCHEDULE
1.
The following substances, namely—
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
2.
The following substances, namely—
1-(Benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives;
1-(Benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives;
1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives;
1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives;
2-(1H-Indol-5-yl)-1-methylethylamine;
2-(1H-Indol-6-yl)-1-methylethylamine.
3.
Any stereoisomeric form of a substance specified in paragraph 1 or 2.
4.
Any salt of a substance specified in any of paragraphs 1 to 3.
5.
Any preparation or other product containing a substance specified in any of paragraphs 1 to 4.